Nirmatrelvir/ Ritonavir: A Novel combination for Tackling COVID-19?

A Novel Drug Combination to Reduce the Progression to Severe COVID-19 Do you think a combination of an antiviral agent and a pharmacokinetic enhancer can lower the risk of COVID-19 progression?� Although current treatments reduce the progression of COVID-19, their efficacy against emerging variants is unclear. A study was conducted to evaluate the safety and efficacy of a nirmatrelvir/ritonavir combination in high-risk, non-hospitalized COVID-19 patients.� Click to Find Out Successful Management of Heterotopic Ossification in COVID: A Case Report A 59-year-old diabetic male presented with dyspnea. He was suffering from a bilateral pleural effusion and COVID-19. Bilateral hip radiographs revealed Booker Grade 3 HO on the right and Booker Grade 2 HO on the left.� Read to know how this case was managed. Read the Case Report How Will You Treat This Case of MIS in a Child with COVID?� A 7-year-old healthy boy presented to the casualty ward with septic shock. He had a fever, vomiting, and diarrhea for five days. Which of the following treatments can help stabilize the patient's condition? A. Increase the dosage of vasopressors B. Continue epinephrine and norepinephrine C. Cease high doses of methylprednisolone D. Start continuous renal replacement therapy using cytokine filters Suggest Treatment Can We Rely on Cough Acoustics to Diagnose Respiratory Diseases? During the pandemic, clinics faced major challenges, including the overwhelming number of patients with COVID-19-like symptoms, complexity in distinguishing between respiratory diseases, and reduced efficiency in assessment. To address these problems, a clinic in Australia has implemented a mobile-based digital diagnostic app that can assess respiratory diseases based on cough acoustics. Read to know if it is reliable! See What's New Docplexus: One of the world's largest online communities of Doctors Pune - 411025, INDIA info@docplexus.co.in | +91-98500 36954 You received this mail because you opted-in to receive promotional mails from Docplexus. Change email preference.